已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Prevalence of drug-resistant pulmonary tuberculosis in India: systematic review and meta-analysis

医学 荟萃分析 流行病学 肺结核 置信区间 生物统计学 内科学 公共卫生 广泛耐药结核 耐药结核 抗药性 环境卫生 结核分枝杆菌 病理 生物 微生物学
作者
Vishal Goyal,Vijay Kadam,Prashant Narang,Vikram Singh
出处
期刊:BMC Public Health [BioMed Central]
卷期号:17 (1): 817-817 被引量:78
标识
DOI:10.1186/s12889-017-4779-5
摘要

Drug-resistant pulmonary tuberculosis (DR-TB) is a significant public health issue that considerably deters the ongoing TB control efforts in India. The purpose of this review was to investigate the prevalence of DR-TB and understand the regional variation in resistance pattern across India from 1995 to 2015, based on a large body of published epidemiological studies. A systematic review of published studies reporting prevalence of DR-TB from biomedical databases (PubMed and IndMed) was conducted. Meta-analysis was performed using random effects model and the pooled prevalence estimate (95% confidence interval [CI]) of DR-TB, multidrug resistant (MDR-) TB, pre-extensively drug-resistant (pre-XDR) TB and XDR-TB were calculated across two study periods (decade 1: 1995 to 2005; decade 2: 2006 to 2015), countrywide and in different regions. Heterogeneity in this meta-analysis was assessed using I 2 statistic. A total of 75 of 635 screened studies that fulfilled the inclusion criteria were selected. Over 40% of 45,076 isolates suspected for resistance to any first-line anti-TB drugs tested positive. Comparative analysis revealed a worsening trend in DR-TB between the two study decades (decade 1: 37.7% [95% CI = 29.0; 46.4], n = 25 vs decade 2: 46.1% [95% CI = 39.0; 53.2], n = 36). The pooled estimate of MDR-TB resistance was higher in previously treated patients (decade 1: 29.8% [95% CI = 20.7; 39.0], n = 13; decade 2: 35.8% [95% CI = 29.2; 42.4], n = 24) as compared with the newly diagnosed cases (decade 1: 4.1% [95% CI = 2.7; 5.6], n = 13; decade 2: 5.6% [95% CI = 3.8; 7.4], n = 17). Overall, studies from Western states of India reported highest prevalence of DR-TB (57.8% [95% CI = 37.4; 78.2], n = 6) and MDR-TB (39.9% [95% CI = 21.7; 58.0], n = 6) during decade 2. Prevalence of pre-XDR TB was 7.9% (95% CI = 4.4; 11.4, n = 5) with resistance to fluoroquinolone (66.3% [95% CI = 58.2; 74.4], n = 5) being the highest. The prevalence of XDR-TB was 1.9% (95% CI = 1.2; 2.6, n = 14) over the 20-year period. The alarming increase in the trend of anti-TB drug resistance in India warrants the need for a structured nationwide surveillance to assist the National TB Control Program in strengthening treatment strategies for improved outcomes.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
超级诗桃完成签到,获得积分10
2秒前
2秒前
Akim的应助被AdamJie采纳,获得10
4秒前
高兴万天完成签到,获得积分10
4秒前
4秒前
5秒前
机智的白卉的应助被研友_LNoAMn采纳,获得200
5秒前
奋斗舞仙完成签到 ,获得积分10
6秒前
Sapphire完成签到 ,获得积分10
6秒前
yangching完成签到,获得积分10
6秒前
8秒前
科研通AI6.4的应助被Sasha采纳,获得10
9秒前
vc发布了新的文献求助10
9秒前
Lucas的应助被刻苦乐天采纳,获得10
11秒前
roro熊完成签到 ,获得积分10
12秒前
兰岚完成签到,获得积分10
13秒前
王化省发布了新的文献求助10
14秒前
ll完成签到 ,获得积分10
16秒前
konnie完成签到 ,获得积分10
17秒前
18秒前
36hours完成签到,获得积分10
21秒前
瓶子完成签到 ,获得积分10
21秒前
JamesPei的应助被隐形的晓灵采纳,获得10
23秒前
科研小秦完成签到,获得积分10
23秒前
23秒前
学术小菜鸟完成签到 ,获得积分10
24秒前
27秒前
28秒前
刻苦乐天发布了新的文献求助10
28秒前
飘逸盛男完成签到,获得积分10
30秒前
难过元灵完成签到 ,获得积分10
30秒前
33秒前
chiaoyin999发布了新的文献求助10
34秒前
fantasy的应助被二千采纳,获得10
35秒前
李爱国的应助被vc采纳,获得10
35秒前
37秒前
37秒前
乐乐的应助被丸子采纳,获得10
39秒前
39秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184889
求助须知:如何正确求助?哪些是违规求助? 9573836
关于积分的说明 21833242
捐赠科研通 7782263
什么是DOI,文献DOI怎么找? 3434429
关于科研通互助平台的介绍 2558581
邀请新用户注册赠送积分活动 2481082